Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1993-11-12
1998-11-17
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514211, 5142288, 514241, 514242, 514249, 514256, 514259, 514263, 514270, 514274, 514309, 514312, 514315, 514348, 514357, 514374, 514400, 514425, 514427, 540467, 540544, 544216, 544257, 544272, 544286, 544301, 544311, 544335, 546 96, 546141, 546142, 546157, 546246, 546296, 546334, 548215, 5483401, 548485, 548546, 548561, A61K 3155, A61K 31515, A61K 31445, A61K 3152
Patent
active
058377034
ABSTRACT:
Therapeutic compounds have the formula:
REFERENCES:
patent: 3422107 (1969-01-01), Mohler et al.
patent: 3737433 (1973-06-01), Mohler et al.
patent: 4515795 (1985-05-01), Hinze et al.
patent: 4576947 (1986-03-01), Hinze et al.
patent: 4636507 (1987-01-01), Kruetzer et al.
patent: 4638070 (1987-01-01), Lambelin et al.
patent: 4668786 (1987-05-01), Thiele et al.
patent: 4833146 (1989-05-01), Gebert et al.
patent: 4965271 (1990-10-01), Mandell et al.
patent: 5039666 (1991-08-01), Novick et al.
patent: 5096906 (1992-03-01), Mandell et al.
patent: B13737433 (1987-03-01), Mohler et al.
Bianco et al., Blood, 76:Supplement 1 (522), p. 133a, "Pentoxifylline (PTX) and GM-CSF Decrease Tumor Necrosis Factor Alpha (TNF-.alpha.) Levels in Patients Undergoing Allogeneic Bone Marrow Transplantation (BMT)," 1991.
Davis et al., Applied Environment Microbial, 48:2, pp. 327-331, "Microbial Models of Mammalian Metabolism: Microbial Reduction and Oxidation of Pentoxfylline," Aug. 1984.
Fuhrer et al., J. Med. Chem., vol. 27, pp. 831-836, ".beta.-Adrenergic Blocking Agents: Substituted Phenylakanolamines. Effect of Side-Chain Length on .beta.-Blocking Potency in Vitro", 1984.
Bariana et al., Chimie Therapeutique, No. 2, pp. 101-104, "Xanthine Derivatives as Coronary Vasodilators", Mar.-Apr. 1971.
Chemical Abstracts, vol. 57: Col. 13140h-13141b, 1962.
Chemical Abstracts, vol. 58: Col. 10211c-10214g, 1963.
Chemical Abstracts, vol. 60: Col. 4140g, 1964.
Chemical Abstracts, vol. 70: No. 29155k, p. 350, 1969.
Chemical Abstracts, vol. 71: No. 30615n, p. 314, 1969.
Chemical Abstracts, vol. 75: No. 129988f, p. 313, 1971.
Chemical Abstracts, vol. 99: No. 105059y, p. 568, 1983.
Klein J. Peter
Kumar Anil M.
Michnick John
Rice Glenn C.
Underiner Gail E.
Cebulak Mary C.
Cell Therapeutics Inc.
Faciszewski Stephen
Oster Jeffrey B.
Raymond Richard L.
LandOfFree
Amino-alcohol substituted cyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amino-alcohol substituted cyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino-alcohol substituted cyclic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-884638